Selected research
Market Structure
Global Prescription & Rx Sunglass Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Prescription & Rx Sunglass market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Prescription & Rx Sunglass is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Prescription & Rx Sunglass is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Prescription & Rx Sunglass is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Prescription & Rx Sunglass is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Prescription & Rx Sunglass include Safilo (France), Rodenstock, Marchon, Luxottica, Hoya Corporation, Fielmann, Essilor (France), De Rigo and Charmant, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Prescription & Rx Sunglass market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Prescription & Rx Sunglass and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Prescription & Rx Sunglass sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Prescription & Rx Sunglass market size, projected growth trends, production technologies, key applications, and end-use industries.
Prescription & Rx Sunglass Segment by Company
Safilo (France)
Rodenstock
Marchon
Luxottica
Hoya Corporation
Fielmann
Essilor (France)
De Rigo
Charmant
Carl Zeiss
Bausch & Lomb
Prescription & Rx Sunglass Segment by Type
Polycarbonate
Polyurethane
Glass
CR-39
Prescription & Rx Sunglass Segment by Application
Hazardous Environments
Others
Prescription & Rx Sunglass Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prescription & Rx Sunglass market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Prescription & Rx Sunglass and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prescription & Rx Sunglass.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Prescription & Rx Sunglass market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prescription & Rx Sunglass manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Prescription & Rx Sunglass in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Prescription & Rx Sunglass in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Polycarbonate
- Polyurethane
- Glass
- CR-39
Applications
- Hazardous Environments
- Others
Companies covered
- Safilo (France)
- Rodenstock
- Marchon
- Luxottica
- Hoya Corporation
- Fielmann
- Essilor (France)
- De Rigo
- Charmant
- Carl Zeiss
- Bausch & Lomb
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Prescription & Rx Sunglass Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Prescription & Rx Sunglass Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Prescription & Rx Sunglass Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Prescription & Rx Sunglass Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Prescription & Rx Sunglass Market Dynamics
- 2.1 Prescription & Rx Sunglass Industry Trends
- 2.2 Prescription & Rx Sunglass Industry Drivers
- 2.3 Prescription & Rx Sunglass Industry Opportunities and Challenges
- 2.4 Prescription & Rx Sunglass Industry Restraints
3 Prescription & Rx Sunglass Market by Manufacturers
- 3.1 Global Prescription & Rx Sunglass Revenue by Manufacturers (2021-2026)
- 3.2 Global Prescription & Rx Sunglass Sales by Manufacturers (2021-2026)
- 3.3 Global Prescription & Rx Sunglass Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Prescription & Rx Sunglass Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Prescription & Rx Sunglass Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Prescription & Rx Sunglass Manufacturers, Product Type & Application
- 3.7 Global Prescription & Rx Sunglass Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Prescription & Rx Sunglass Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Prescription & Rx Sunglass Players Market Share by Revenue in 2025
- 3.8.3 2025 Prescription & Rx Sunglass Tier 1, Tier 2, and Tier 3
4 Prescription & Rx Sunglass Market by Type
- 4.1 Prescription & Rx Sunglass Type Introduction
- 4.1.1 Polycarbonate
- 4.1.2 Polyurethane
- 4.1.3 Glass
- 4.1.4 CR-39
- 4.2 Global Prescription & Rx Sunglass Sales by Type
- 4.2.1 Global Prescription & Rx Sunglass Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Prescription & Rx Sunglass Sales by Type (2021-2032)
- 4.2.3 Global Prescription & Rx Sunglass Sales Market Share by Type (2021-2032)
- 4.3 Global Prescription & Rx Sunglass Revenue by Type
- 4.3.1 Global Prescription & Rx Sunglass Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Prescription & Rx Sunglass Revenue by Type (2021-2032)
- 4.3.3 Global Prescription & Rx Sunglass Revenue Market Share by Type (2021-2032)
5 Prescription & Rx Sunglass Market by Application
- 5.1 Prescription & Rx Sunglass Application Introduction
- 5.1.1 Hazardous Environments
- 5.1.2 Others
- 5.2 Global Prescription & Rx Sunglass Sales by Application
- 5.2.1 Global Prescription & Rx Sunglass Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Prescription & Rx Sunglass Sales by Application (2021-2032)
- 5.2.3 Global Prescription & Rx Sunglass Sales Market Share by Application (2021-2032)
- 5.3 Global Prescription & Rx Sunglass Revenue by Application
- 5.3.1 Global Prescription & Rx Sunglass Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Prescription & Rx Sunglass Revenue by Application (2021-2032)
- 5.3.3 Global Prescription & Rx Sunglass Revenue Market Share by Application (2021-2032)
6 Global Prescription & Rx Sunglass Sales by Region
- 6.1 Global Prescription & Rx Sunglass Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Prescription & Rx Sunglass Sales by Region (2021-2032)
- 6.2.1 Global Prescription & Rx Sunglass Sales by Region (2021-2026)
- 6.2.2 Global Prescription & Rx Sunglass Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Prescription & Rx Sunglass Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Prescription & Rx Sunglass Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Prescription & Rx Sunglass Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Prescription & Rx Sunglass Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Prescription & Rx Sunglass Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Prescription & Rx Sunglass Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Prescription & Rx Sunglass Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Prescription & Rx Sunglass Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Prescription & Rx Sunglass Revenue by Region
- 7.1 Global Prescription & Rx Sunglass Revenue by Region
- 7.1.1 Global Prescription & Rx Sunglass Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Prescription & Rx Sunglass Revenue by Region (2021-2026)
- 7.1.3 Global Prescription & Rx Sunglass Revenue by Region (2027-2032)
- 7.1.4 Global Prescription & Rx Sunglass Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Prescription & Rx Sunglass Revenue (2021-2032)
- 7.2.2 North America Prescription & Rx Sunglass Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Prescription & Rx Sunglass Revenue (2021-2032)
- 7.3.2 Europe Prescription & Rx Sunglass Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Prescription & Rx Sunglass Revenue (2021-2032)
- 7.4.2 Asia-Pacific Prescription & Rx Sunglass Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Prescription & Rx Sunglass Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Prescription & Rx Sunglass Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Safilo (France)
- 8.1.1 Safilo (France) Company Information
- 8.1.2 Safilo (France) Business Overview
- 8.1.3 Safilo (France) Prescription & Rx Sunglass Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Safilo (France) Prescription & Rx Sunglass Product Portfolio
- 8.1.5 Safilo (France) Recent Developments
- 8.2 Rodenstock
- 8.2.1 Rodenstock Company Information
- 8.2.2 Rodenstock Business Overview
- 8.2.3 Rodenstock Prescription & Rx Sunglass Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Rodenstock Prescription & Rx Sunglass Product Portfolio
- 8.2.5 Rodenstock Recent Developments
- 8.3 Marchon
- 8.3.1 Marchon Company Information
- 8.3.2 Marchon Business Overview
- 8.3.3 Marchon Prescription & Rx Sunglass Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Marchon Prescription & Rx Sunglass Product Portfolio
- 8.3.5 Marchon Recent Developments
- 8.4 Luxottica
- 8.4.1 Luxottica Company Information
- 8.4.2 Luxottica Business Overview
- 8.4.3 Luxottica Prescription & Rx Sunglass Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Luxottica Prescription & Rx Sunglass Product Portfolio
- 8.4.5 Luxottica Recent Developments
- 8.5 Hoya Corporation
- 8.5.1 Hoya Corporation Company Information
- 8.5.2 Hoya Corporation Business Overview
- 8.5.3 Hoya Corporation Prescription & Rx Sunglass Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Hoya Corporation Prescription & Rx Sunglass Product Portfolio
- 8.5.5 Hoya Corporation Recent Developments
- 8.6 Fielmann
- 8.6.1 Fielmann Company Information
- 8.6.2 Fielmann Business Overview
- 8.6.3 Fielmann Prescription & Rx Sunglass Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Fielmann Prescription & Rx Sunglass Product Portfolio
- 8.6.5 Fielmann Recent Developments
- 8.7 Essilor (France)
- 8.7.1 Essilor (France) Company Information
- 8.7.2 Essilor (France) Business Overview
- 8.7.3 Essilor (France) Prescription & Rx Sunglass Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Essilor (France) Prescription & Rx Sunglass Product Portfolio
- 8.7.5 Essilor (France) Recent Developments
- 8.8 De Rigo
- 8.8.1 De Rigo Company Information
- 8.8.2 De Rigo Business Overview
- 8.8.3 De Rigo Prescription & Rx Sunglass Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 De Rigo Prescription & Rx Sunglass Product Portfolio
- 8.8.5 De Rigo Recent Developments
- 8.9 Charmant
- 8.9.1 Charmant Company Information
- 8.9.2 Charmant Business Overview
- 8.9.3 Charmant Prescription & Rx Sunglass Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Charmant Prescription & Rx Sunglass Product Portfolio
- 8.9.5 Charmant Recent Developments
- 8.10 Carl Zeiss
- 8.10.1 Carl Zeiss Company Information
- 8.10.2 Carl Zeiss Business Overview
- 8.10.3 Carl Zeiss Prescription & Rx Sunglass Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Carl Zeiss Prescription & Rx Sunglass Product Portfolio
- 8.10.5 Carl Zeiss Recent Developments
- 8.11 Bausch & Lomb
- 8.11.1 Bausch & Lomb Company Information
- 8.11.2 Bausch & Lomb Business Overview
- 8.11.3 Bausch & Lomb Prescription & Rx Sunglass Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Bausch & Lomb Prescription & Rx Sunglass Product Portfolio
- 8.11.5 Bausch & Lomb Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Prescription & Rx Sunglass Value Chain Analysis
- 9.1.1 Prescription & Rx Sunglass Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Prescription & Rx Sunglass Production Mode & Process
- 9.2 Prescription & Rx Sunglass Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Prescription & Rx Sunglass Distributors
- 9.2.3 Prescription & Rx Sunglass Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst